Results from the company’s Phase III Mint trial marked a median three-point improvement on a scale used to measure symptom ...

Christopher Ridley, a spokesperson for Moderna, said the state legislative efforts are largely a product of ...

Pancreatic cancer that spreads to the liver is especially difficult to treat because the liver naturally suppresses immune ...

We like the long-term potential for innovation and combinations between drug classes, such as using CAR-T cell therapy in combination with CAR-T cell amplifying mRNA therapy (CARVac) with BNT211 ...

Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...

Phase 3 AURORA trial of Descartes-08 in myasthenia gravis on track to commence in 1H25; Deep and durable responses maintained over 12 months in ...

The research team built its therapy from systems found in nature ... Specifically, the way cells make proteins is by turning on a gene, which, in turn, makes mRNA, a genetic messenger released to ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...